A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom

International Journal of Clinical Practice

Volumn 68, Issue 10, 2014, Pages 1200-1208

  Covvey, J R ^a   Mullen, A B ^a   Ryan, M ^b   Steinke, D T ^c   Johnston, B F ^a   Wood, F T ^d   Boyter, A C ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE; BRONCHODILATING AGENT;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; ADOLESCENT; COHORT ANALYSIS; EPIDEMIOLOGY; GREAT BRITAIN; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VERY ELDERLY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84908200474     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12451     Document Type: Article

References (40)

1. World Health Organization (WHO). Adherence to long-term therapies: evidence for action, 2003. http://www.who.int/chp/knowledge/publications/adherence-full-report.pdf (accessed 12 February 2013).
2. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-7.
3. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X,. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; 16: CD000011.
4. DiMatteo MR,. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200-9.
5. Bender B, Milgrom H, Rand C,. Nonadherance in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol 1997; 79: 177-85.
6. Gamble J, Stevenson M, McClean E, Heaney LG,. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009; 180: 817-22.
7. Horne R,. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130: 65S-72S.
8. Bourbeau J, Bartlett SJ,. Patient adherence in COPD. Thorax 2008; 63: 831-8.
9. Laforest L, Denis F, Van Ganse E, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J 2010; 19: 148-54.
10. Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008; 3: 371-84.
11. DiMatteo MR, Haskard KB, Williams SL,. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care 2007; 45: 521-8.
12. Jones RCM, Price D, Ryan D, et al.; on behalf of the Respiratory Effectiveness Group. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014; 2: 267-76.
13. Krigsman K, Moen J, Nilsson JL, Ring L,. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007; 32: 603-11.
14. Haupt D, Krigsman K, Nilsson JL,. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 2008; 30: 509-14.
15. Asthma UK. Wish you were here? UK report, 2008. http://news.bbc.co.uk/1/shared/bsp/hi/pdfs/06-05-08-asthma-report.pdf (accessed 17 February 2014).
16. British Lung Foundation. Invisible lives: chronic obstructive pulmonary disease (COPD)-finding the missing millions, 2007. http://www.lunguk.org/Resources/British%20Lung%20Foundation/Migrated%20Resources/Documents/I/Invisible%20Lives%20report.pdf (accessed 17 February 2014).
17. Covvey JR, Johnston BF, Wood F, Boyter AC,. Is the BTS/SIGN guideline confusing? A retrospective database analysis of asthma therapy. Prim Care Respir J 2013; 22: 290-5.
18. Elkout H, Helms PJ, Simpson CR, McLay JS,. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. PLoS ONE 2012; 7: e39130.
19. Haupt D, Nilsson JL,. Asthma medication-persistence with adrenergics, steroids and combination products over a 5-year period. J Clin Pharm Ther 2009; 34: 507-13.
20. Krigsman K, Nilsson JLG, Ring L,. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 2007; 16: 441-8.
21. Andrade SE, Kahler KH, Frech F, Chan KA,. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-74; discussion 575-7.
22. Sikka R, Xia F, Aubert RE,. Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11: 449-57.
23. Jung E, Pickard AS, Salmon JW, Bartle B, Lee TA,. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009; 103: 525-34.
24. Bender BG, Pedan A, Varasteh LT,. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006; 118: 899-904.
25. Rand CS, Nides M, Cowles MK, Wise RA, Connett J,. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med 1995; 152: 580-8.
26. Gellad WF, Grenard JL, Marcum ZA,. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9: 11-23.
27. Murphy AC, Proeschal A, Brightling CE, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012; 67: 751-3.
28. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114: 1288-93.
29. Simoni-Wastila L, Wei YJ, Qian J, et al. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Am J Geriatr Pharmacother 2012; 10: 201-10.
30. Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011; 128: 1185-91.e2.
31. Walders N, Kopel SJ, Koinis-Mitchell D, McQuaid EL,. Patterns of quick-relief and long-term controller medication use in pediatric asthma. J Pediatr 2005; 146: 177-82.
32. Horne R, Weinman J,. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-67.
33. Kucukarslan SN,. A review of published studies of patients' illness perceptions and medication adherence: lessons learned and future directions. Res Social Adm Pharm 2012; 8: 371-82.
34. Watson L, Vestbo J, Postma DS, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004; 98: 1207-13.
35. Cramer JA, Bradley-Kennedy C, Scalera A,. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007; 14: 25-9.
36. Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM,. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007; 101: 1398-405.
37. Coleman CI, Limone B, Sobieraj DM, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm 2012; 18: 527-39.
38. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L,. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy 2001; 21: 1464-7.
39. Maspero JF, Dueñas-Meza E, Volovitz B, et al. Oral montelukast versus inhaled beclomethasone in 6-to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin 2001; 17: 96-104.
40. Zeber JE, Manias E, Williams AF, et al.; ISPOR Medication Adherence Good Research Practices Working Group. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR Medication Adherence & Persistence Special Interest Group. Value Health 2013; 16: 891-900.